In a clinical intervention trial on PES treatment to foster removal of the tracheal cannula in severely dysphagic, tracheostomized stroke patients an increased Substance P concentration after PES was indicative of decannulation success due to a relevant improvement of swallowing function (Muhle et al., 2017). The gene discussed is TAC1; the disease is stroke disorder.